David Grierson
21Patents
5h-index
42Co-inventors
69Inventor score
Filing activity: Nov 13, 1992 → Oct 5, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7718676B2 | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors | Chemistry; Metallurgy | 29 | Active |
| US5292921A | Process for the enantioselective preparation of phenylisoserine derivatives | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6683079B2 | 3-(amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases | Chemistry; Metallurgy | 7 | Expired |
| US9079351B2 | System for transfer of nanomembrane elements with improved preservation of spatial integrity | Emerging Cross-Sectional Technologies | 7 | Active |
| US7115608B2 | Pyridinone and pyridinethione derivatives having HIV inhibiting properties | Chemistry; Metallurgy | 5 | Expired |
| US6451822B1 | 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases | Chemistry; Metallurgy | 3 | Expired |
| US9233931B2 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Chemistry; Metallurgy | 3 | Active |
| US7981400B2 | Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors | Human Necessities | 3 | Active |
| US8604063B2 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Chemistry; Metallurgy | 3 | Active |
| US7371742B2 | Porphyrin derivatives for photodynamic therapy | Chemistry; Metallurgy | 3 | Expired |
| US7718601B2 | Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors | Human Necessities | 3 | Active |
| US8313731B2 | Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors | Human Necessities | 2 | Active |
| US10130595B2 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Chemistry; Metallurgy | 2 | Active |
| US8658659B2 | Substituted oxazole derivatives and their use as tyrosine kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7728128B2 | Dibenzo[c,h][1,5]naphthyridines and their use as DNA probes | Emerging Cross-Sectional Technologies | 0 | Active |
| US7989467B2 | Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process | Chemistry; Metallurgy | 0 | Active |
| US8110591B2 | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10857773B2 | System for transfer of nanomembrane elements with improved preservation of spatial integrity | Emerging Cross-Sectional Technologies | 0 | Active |
| US10196345B2 | MAO-B selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8895726B2 | Compounds derived from indole and pharmaceutical compositions containing them | Chemistry; Metallurgy | 0 | Active |
| US10654813B2 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.